₨ 1,309.33
MBBS
Methotrexate Injection 50 mg 1 Vialx20 mL
- Does this requires a prescription ? Yes
- Generic Name: Methotrexate
- Manufactured by : Pfizer
- Drug Strength : 50 mg
- Drug Form : Injection
- Pack Size : 1 Vialx20 mL
- Product SKU : pg_14564_20378
Methotrexate Injection contains Methotrexate | belongs to Folic acid antagonist
Alternate brands of Methotrexate Injection 50 mg 1 Vialx20 mL
Brand Name | Price | Savings |
---|---|---|
Metrex (methotrexate) Tablet 2.5 mg 100’s ^ | ₨ 5,000.00 | You will pay -3690.67 more |
Zexate Injection 500 mg 1 Vial | ₨ 1,260.00 | You can save 49.33 |
Unitrexate tablet 10 mg 100’s | ₨ 1,466.00 | You will pay -156.67 more |
Unitrexate tablet 2.5 mg 100’s | ₨ 626.50 | You can save 682.83 |
Unitrexate Injection 1 gm 1 Vial | ₨ 2,558.52 | You will pay -1249.19 more |
How it works
Methotrexate Injection 50 mg 1 Vialx20 mL works by interfering the DNA synthesis and stops the growth of the cells.
Side effects
Major & minor side effects for Methotrexate Injection 50 mg 1 Vialx20 mL
- Diarrhea severe
- Joint pain severe
- Abdominal pain severe
- Swelling of feet or lower legs severe
- Dizziness severe
- Fever with chills severe
- Unusual bleeding severe
- Blurred vision severe
- Temporary Hair Loss
- Loss of appetite
- Nausea or Vomiting
- Pale skin
- Skin rash
Uses of Methotrexate Injection 50 mg 1 Vialx20 mL
What is it prescribed for?
-
Acute Lymphoblastic Leukemia
Methotrexate Injection 50 mg 1 Vialx20 mL is used in the treatment of cancer of the bone marrow that affects the production of white blood cells.
-
Choriocarcinoma
Methotrexate Injection 50 mg 1 Vialx20 mL is used in the treatment of cancer of the women's uterus.
-
Meningeal Leukemia
Methotrexate Injection 50 mg 1 Vialx20 mL is used in the treatment of cancer meningitis which is a thin layer that protects the brain and spinal cord.
-
Breast cancer
Methotrexate Injection 50 mg 1 Vialx20 mL is used with other medications in the treatment of breast cancer.
-
Rheumatoid Arthritis
Methotrexate Injection 50 mg 1 Vialx20 mL is used to relieve the symptoms of inflammation in rheumatoid arthritis.
-
Psoriasis
Methotrexate Injection 50 mg 1 Vialx20 mL is used in the treatment of psoriasis which is an autoimmune skin disease.
Concerns
Frequently asked questions
-
Onset of action
The effect of this medicine can be observed in 1 to 2 hours after an oral dose and 30 to 60 minutes after an intramuscular injection.
-
Duration of Effect
The effect of this medicine lasts for an average duration of 9 to 30 hours at a low dose and 24 to 45 hours at a high dose.
-
Safe with Alchohol?
Consumption of alcohol is not recommended due to the risk of liver injury. Close monitoring of liver enzymes is necessary. Seek immediate medical treatment if any symptoms like lethargy, yellow colored eyes, and skin, abdominal pain appear.
-
Is it habit forming?
No habit forming tendencies were reported.
-
Usage in pregnancy?
This medicine is not recommended for pregnant women.
-
Usage while breast-feeding?
This medicine is not recommended in breastfeeding women.
When not to use?
-
Allergy
Not recommended in patients with known allergy to Methotrexate Injection 50 mg 1 Vialx20 mL .
-
Pregnancy
Not recommended for pregnant women due to the risk of birth defects.
-
Liver disease
Not recommended in patients with the existing liver disease.
-
Blood disorder
Not recommended in patients with existing blood diseases.
Warnings
-
Pregnancy
This medicine is not recommended for pregnant women.
-
Breast-feeding
This medicine is not recommended in breastfeeding women.
-
Liver injury
This medicine is not recommended in the patients with the liver injury. The concentration of this medicine may increase in these patients. The baseline of the liver function tests should be obtained before starting the treatment.
-
Kidney injury
This medicine is not recommended in the patients with the kidney injury. It may cause kidney injury at higher doses. The dose of this medicine should be adjusted based on the CrCl.
-
Lung toxicity
This medicine may cause severe lung injuries like pulmonary fibrosis, pulmonary interstitial infiltrates. Any symptoms of breathing difficulty and signs of lung impairment should be informed to the doctor. The treatment should be discontinued if any symptoms appear.
-
Blood cell count
This medicine may lower the white blood cell count (neutrophils) and platelets. Close monitoring of blood cell count is necessary. The baseline of the blood cell count should be obtained before initiation of the treatment. Do not start the treatment if the counts are less.
-
Skin reactions
The medicine may cause severe skin reactions stevens-johnson syndrome, skin necrosis, and skin ulceration. Inform the doctor if any symptoms appear. The treatment should be discontinued.
-
Gastrointestinal injury
This medicine is not recommended for use in patients with gastrointestinal disorders like diarrhea and ulcerative stomatitis. Inform the doctor if you have any gastrointestinal disorders before initiation of the therapy.
-
Infections
The chances of occurring infections are more in the patients receiving this medicine. Hold the chemotherapy and start with the broad-spectrum antibiotics if there are any signs and symptoms of fever. Close monitoring of the body temperature and the blood cell count is necessary.
Dosage
-
Missed Dose
It is advised not to miss any dose. If you missed any dose, you should contact your doctor immediately.
-
Overdose
Seek emergency medical treatment or contact the doctor in case of an overdose.
Interactions
Interaction with Medicines- Azole antifungal agents moderate
- Atorvastatin moderate
- Live vaccines severe
- Proton pump inhibitors severe
-
severe
Methotrexate Injection 50 mg 1 Vialx20 mL is not recommended for the treatment of psoriasis and rheumatoid arthritis in patients with liver disease. The baseline of the liver enzymes should be obtained before starting the therapy. The treatment should be discontinued if liver enzymes are elevated.
General Instructions
Take Methotrexate Injection 50 mg 1 Vialx20 mL as instructed by your doctor. Do not take in larger amounts than advised. Do not miss any scheduled dose. Consult the doctor if you experience any undesirable effects. Do not stop taking the medicine without consulting your doctor.
Other details
- Can be taken with or without food, as advised by your doctor
- To be taken as instructed by doctor
- May cause sleepiness
References
- practo.com - Methotrexate [Internet]. Available from: https://www.practo.com/medicine-info/methotrexate-177-api [cited 4 octotber 2019]. 16 Nov 2017
- medlineplus.gov - Methotrexate [Internet]. Available from: https://medlineplus.gov/druginfo/meds/a682019.html [cited 4 octotber 2019]. 01 October 2019
- dailymed.nlm.nih.gov - Methotrexate [Internet]. Available from: https://dailymed.nlm.nih.gov/dailymed/drugInfo.cfm?setid=ec476b11-0b3c-4139-b1eb-a3daa76bc271#a15d5648-439e-4a6d-b23d-1c02c0329aff [cited 4 octotber 2019]. April 1, 2016
How to use Methotrexate Injection 50 mg 1 Vialx20 mL
It may be administered IM, IV or IT. IV administration may be slow push, short bolus inf or 24-42 hour continuous inf. Dilute powder with D5W or NS to a conc. of = 25 mg/mL (20 mg and 50 mg vials)and 50 mg/mL (1 gm vial). Intrathecal solutions may be reconstituted to 2.5 to 5 mg/mL with NS, D5W, LR or Elliott’s B solution. Use preservative free preparations for IT or high dose administration.
Stability: Store at 20°C-25°C (68°F-77°F); excursions are permitted to 15°C -30°C (59°F-86°F). Protect from light.
what are the adverse effects of Methotrexate Injection 50 mg 1 Vialx20 mL?
Bone marrow depression, GI upset, hepatotoxicity, skin reactions, opportunistic infections, urino-genital disorders, decreased fertility and pulmonary disease and CNS disturbances.
What happens if I miss a dose of Methotrexate Injection 50 mg 1 Vialx20 mL?
Adults: Antineoplastic: Burkitt’s Lymphoma: Stages I-II: Orally: 10-25 mg/day for 4-8 day for several courses; separate by 7-10 day rest period.
Lymphosarcomas: Stage III: Orally: 0.625-2.5 mg/kg/day.
Leukaemia: Induction: 3.3 mg/m² with prednisone every day. Remission Maintenance: 15 mg/m² Orally/IM twice wkly or 2.5 mg/kg IV every 14 day.
Mycosis fungoides: 5-50 mg every wk. If poor response, give 15-37.5 mg twice wkly.
Osteosarcoma: Initial: 12 gm/m² IV, increase to 15 gm/m² if peak levels of 1000 micro-molar not reached at end of infusion.
Choriocarcinoma/trophoblastic diseases: Orally/IM: 15-30 mg every day x 5 day, rest gt;1 wk & repeat 3-5 times.
Rheumatoid arthritis: Initial: 7.5 mg once wkly or 2.5 mg every 12 hr x 3 doses once wkly. Max: 20 mg/wk. Reduce to lowest effective dose.
Psoriasis: Usual: 10-25 mg/wk Orally/IV/IM until adequate response achieved or use 2.5 mg every 12 hr x 3 doses. Titrate: May increase gradually. Max: 30 mg/wk.
Children: Meningeal leukaemias: Intrathecal: Dilute preservative free Methotrexate to 1 mg/mL. Dose every 2-5 day. gt;3 yr: 12 mg. 2 yr: 10 mg. 1 yr: 8 mg. lt;1 yr: 6 mg.
Juvenile rheumatoid arthritis: Children 2-16 yr: 10 mg/m² once wkly. Adjust dose to optimal response.
One of the following licensed pharmacy from the nearest location will deliver Methotrexate Injection 50 mg 1 Vialx20 mL. The details of the licensed pharmacy shall be shared once you request the drugs and the respective pharmacy accepts your request based on valid prescription and availability.
Questions and Answers
There are no questions yet. Be the first to ask a question about this product.
Related products
-
Women’s Rogaine 5% Minoxidil Foam for Hair Thinning and Loss, Topical Treatment for Women’s Hair Regrowth, 4-Month Supply
Medicine & HealthRated 5.00 out of 5₨ 15,000.00₨ 14,000.00
Products listed on medicalstore.com.pk are 100% genuine and sourced from licensed pharmacies.
We work hard to bring you unimaginable discounts without compromising on quality.
We uses SSL (standard security technology) to ensure data privacy of all our customers.
Reviews
There are no reviews yet.